Search research articles
Contact Us
Filters
Showing results (151-160 of 180) with videos related to
Page
of 18
Sort By:
The Journal of Antimicrobial Chemotherapy
|
March 22, 2008
First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort
Pere Domingo, Ignacio Suárez-Lozano, Ferran Torres, et al.
Journal of Nephrology
|
December 20, 2019
Combination of calcineurin and mTOR inhibitors in kidney transplantation: a propensity score analysis based on current clinical practice
David Cucchiari, José Ríos, Alicia Molina-Andujar, et al.
Journal of Hepatology
|
September 16, 2021
Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis
Adrià Juanola, Isabel Graupera, Chiara Elia, et al.
Journal of Hepatology
|
April 5, 2026
Erratum to 'BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update' [J Hepatol (2026) 631-654]
Maria Reig, Marco Sanduzzi-Zamparelli, Alejandro Forner, et al.
Journal of Hepatology
|
October 28, 2025
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update
Maria Reig, Marco Sanduzzi-Zamparelli, Alejandro Forner, et al.
Hepatology (Baltimore, Md.)
|
February 28, 2019
Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study
Patricia Huelin, Elsa Solà, Chiara Elia, et al.
Journal of Hepatology
|
December 2, 2021
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules
Marco Sanduzzi-Zamparelli, Zoe Mariño, Sabela Lens, et al.
BMC Gastroenterology
|
February 3, 2025
Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
Núria Granel, Gemma Iserte, Concepció Bartres, et al.
Alimentary Pharmacology & Therapeutics
|
February 23, 2026
Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial)
Marco Sanduzzi-Zamparelli, Ana Matilla, José Luis Lledo, et al.
Journal of Hepatology
|
September 8, 2020
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium
Elsa Solà, Elisa Pose, Daniela Campion, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 180) with videos related to
Sort By:
Page
of 18
The Journal of Antimicrobial Chemotherapy
|
March 22, 2008
First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort
Pere Domingo, Ignacio Suárez-Lozano, Ferran Torres, et al.
Journal of Nephrology
|
December 20, 2019
Combination of calcineurin and mTOR inhibitors in kidney transplantation: a propensity score analysis based on current clinical practice
David Cucchiari, José Ríos, Alicia Molina-Andujar, et al.
Journal of Hepatology
|
September 16, 2021
Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis
Adrià Juanola, Isabel Graupera, Chiara Elia, et al.
Journal of Hepatology
|
April 5, 2026
Erratum to 'BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update' [J Hepatol (2026) 631-654]
Maria Reig, Marco Sanduzzi-Zamparelli, Alejandro Forner, et al.
Journal of Hepatology
|
October 28, 2025
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update
Maria Reig, Marco Sanduzzi-Zamparelli, Alejandro Forner, et al.
Hepatology (Baltimore, Md.)
|
February 28, 2019
Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study
Patricia Huelin, Elsa Solà, Chiara Elia, et al.
Journal of Hepatology
|
December 2, 2021
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules
Marco Sanduzzi-Zamparelli, Zoe Mariño, Sabela Lens, et al.
BMC Gastroenterology
|
February 3, 2025
Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
Núria Granel, Gemma Iserte, Concepció Bartres, et al.
Alimentary Pharmacology & Therapeutics
|
February 23, 2026
Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial)
Marco Sanduzzi-Zamparelli, Ana Matilla, José Luis Lledo, et al.
Journal of Hepatology
|
September 8, 2020
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium
Elsa Solà, Elisa Pose, Daniela Campion, et al.
Page
of 18